Technical Analysis for CPIX - Cumberland Pharmaceuticals Inc.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| See historical CPIX trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bullish Centerline Cross | Bullish | 0.00% | |
| MACD Bullish Signal Line Cross | Bullish | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Volume Surge | Other | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Crossed Above 200 DMA | Bullish | 8.33% | |
| Crossed Above 20 DMA | Bullish | 8.33% |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/14/2019
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, engages in the acquisition, development, and commercialization of branded prescription products for the hospital acute care and gastroenterology markets primarily in the United States. Its principal products include Acetadote, an intravenous formulation of N-acetylcysteine indicated for the treatment of acetaminophen poisoning; Caldolor, an intravenous formulation of ibuprofen for the treatment of pain and fever; and Kristalose, a prescription laxative administered orally for the treatment of constipation. It also develops Hepatoren injection, which is in Phase II clinical development for the treatment of hepatorenal syndrome. The company markets and sells its products through sales representatives and managers. Cumberland Pharmaceuticals, Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.
Medicine Chemistry Pharmaceutical Pain Drugs Medication Analgesics Hepatotoxins Fever Prescription Products Constipation Hepatorenal Syndrome Ibuprofen Paracetamol
Medicine Chemistry Pharmaceutical Pain Drugs Medication Analgesics Hepatotoxins Fever Prescription Products Constipation Hepatorenal Syndrome Ibuprofen Paracetamol
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more CPIX news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 7.0 |
| 52 Week Low | 4.8344 |
| Average Volume | 13,211 |
| 200-Day Moving Average | 5.8646 |
| 50-Day Moving Average | 5.8631 |
| 20-Day Moving Average | 5.796 |
| 10-Day Moving Average | 5.899 |
| Average True Range | 0.4463 |
| ADX | 16.81 |
| +DI | 24.7831 |
| -DI | 16.1132 |
| Chandelier Exit (Long, 3 ATRs ) | 5.1611 |
| Chandelier Exit (Short, 3 ATRs ) | 6.3989 |
| Upper Bollinger Band | 6.4098 |
| Lower Bollinger Band | 5.1822 |
| Percent B (%b) | 1.07 |
| BandWidth | 21.180124 |
| MACD Line | 0.0241 |
| MACD Signal Line | -0.0257 |
| MACD Histogram | 0.0499 |
| Fundamentals | Value |
|---|---|
| Market Cap | 103.32 Million |
| Num Shares | 15.9 Million |
| EPS | -0.44 |
| Price-to-Earnings (P/E) Ratio | -14.77 |
| Price-to-Sales | 3.18 |
| Price-to-Book | 1.73 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 7.10 | ||||
| Resistance 3 (R3) | 7.03 | 6.77 | 7.00 | ||
| Resistance 2 (R2) | 6.77 | 6.61 | 6.80 | 6.97 | |
| Resistance 1 (R1) | 6.63 | 6.52 | 6.70 | 6.70 | 6.93 |
| Pivot Point | 6.37 | 6.37 | 6.40 | 6.40 | 6.37 |
| Support 1 (S1) | 6.23 | 6.21 | 6.30 | 6.30 | 6.07 |
| Support 2 (S2) | 5.97 | 6.12 | 6.00 | 6.03 | |
| Support 3 (S3) | 5.83 | 5.97 | 6.00 | ||
| Support 4 (S4) | 5.90 |
